Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases

Podobne knjige/članki

• RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
  od: Vauthey, Jean-Nicolas, et al.
  Izdano: (2013)
• KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
  od: Vauthey, J-N, et al.
  Izdano: (2012)
• Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate
  od: Andreou, Andreas, et al.
  Izdano: (2011)
• RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases
  od: Zimmitti, Giuseppe, et al.
  Izdano: (2014)
• Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
  od: Andreou, Andreas, et al.
  Izdano: (2013)